Allan Kirk - Oct 2, 2023 Form 3 Insider Report for Eledon Pharmaceuticals, Inc. (ELDN)

Role
Director
Signature
/s/ Paul Little, as attorney-in-fact for Allan Kirk, M.D., PhD
Stock symbol
ELDN
Transactions as of
Oct 2, 2023
Transactions value $
$0
Form type
3
Date filed
10/2/2023, 05:08 PM

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney No securities beneficially owned.